Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno‐Oncology Database
ICI-IA frequently persists after ICI discontinuation. Chronic ICI-IA is associated with improved PFS, but not OS, as compared to acute ICI-IA.
Authors
- Tatiana Nevskaya
- Emma Schmidt
- Alexandra Ladouceur (ORCID: https://orcid.org/0009-0009-3755-4860)
- A. Karmali
- Janet Roberts (ORCID: https://orcid.org/0000-0002-3787-8541)
- Janet Pope (ORCID: https://orcid.org/0000-0003-1479-5302)
- L. Cho
- Sabrina Hoa (ORCID: https://orcid.org/0000-0002-9466-5729)
- David Moon (ORCID: https://orcid.org/0000-0003-1620-836X)
- Nader Toban
- Alexandra Saltman (ORCID: https://orcid.org/0000-0002-0962-9003)
- Shahin Jamal (ORCID: https://orcid.org/0000-0001-5870-3567)
- Megan E. Himmel
- Carrie Ye (ORCID: https://orcid.org/0000-0002-9858-5398)
- Lourdes Gonzalez Arreola
- Thomas Barnetche (ORCID: https://orcid.org/0000-0002-0975-8534)
- Inés Colmegna (ORCID: https://orcid.org/0000-0002-8091-8334)
- Marie Hudson (ORCID: https://orcid.org/0000-0001-6718-2468)
Institutions
- Western University (CA)
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Toronto (CA)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Research Canada (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- ACR Open Rheumatology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/acr2.70002
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- Canadian Institutes of Health Research